The "other" signaling of trastuzumab: antibodies are immunocompetent drugs.
Gianni
Luca
L
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D011961:Receptors, Fc / Q000378:metabolism*; D015398:Signal Transduction; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011961:Receptors, Fc; D000068878:Trastuzumab